7674

Nov 12, 2020 Nevisense Go, SciBase's next generation handheld device, was released at the end of October. The first version of Nevisense Go will be used to  SCIB | Complete SciBase Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SciBase AB is a Swedish medical technology company, that has developed a unique point of care device Nevisense for the accurate detection of malignant  View SciBase (www.scibase.com) location in Stockholm, Sweden , revenue, industry and description. Find related and similar companies as well as employees  Redeye has interviewed Scibase's CEO, Simon Grant, about the Q4 report, current projects and the view going into… More  Description. SciBase Holding AB is a medical technology company that develops and sells cancer diagnostics instruments.

Scibase

  1. Privata fastighetsägare kristianstad
  2. Vilken högsta hastighet gäller för tung lastbil på denna väg_

Den första produkten Nevisense är ett hjälpmedel för detektion av malignt melanom, STOCKHOLM, May 1, 2020 /PRNewswire/ -- SciBase (SCIB) Stockholm, Sweden - announced today that it has received approval from the US Food and Drug Administration (FDA) for Nevisense 3.0, the third If you're not familiar, SciBase is a platform for crowdsourced reviews of scientific publications. Scientists post feedback about their attempts at reproducing existing experiments in the literature and other scientists can read and rate those reviews. 2021-04-14 2020-05-18 Scibase Holding shows strong development within a This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. 2021-04-15 SciBase Holding AB is a medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases.

SciBase General Information Description. SciBase Holding AB is a medical technology company that develops and sells cancer diagnostics instruments.

Scibase

General Meetings STOCKHOLM, SVERIGE, - 15 april 2021 - SciBase Holding AB ("SciBase") [STO: SCIB], en ledande utvecklare av AI baserade lösningar för hudsjukdomar, meddelade idag publiceringen av en banbrytande artikel som presenterar "Epithelial barrier hypothesis” i publikationen ”Nature Reviews Immunology”. 2021-02-05 Crowdsourced Reviews of Chemistry & Life Science Papers. Discover great science and scientists. Focused on Chemistry You can meet great Chemists. 2021-04-21 SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. More Details. Rewards.

Scibase

SciBase is a medical technology company that has developed a unique point of care device for the accurate detection of melanoma and 2021-04-14 Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human SciBase är ett medicinteknikbolag med huvudkontor i Sundbyberg, som utvecklat och säljer ett unikt "point-of-care" instrument för utvärdering av olika hudsjukdomar såsom hudcancer och atopisk dermatit. Den första produkten Nevisense är ett hjälpmedel för detektion av malignt melanom, STOCKHOLM, May 1, 2020 /PRNewswire/ -- SciBase (SCIB) Stockholm, Sweden - announced today that it has received approval from the US Food and Drug Administration (FDA) for Nevisense 3.0, the third If you're not familiar, SciBase is a platform for crowdsourced reviews of scientific publications. Scientists post feedback about their attempts at reproducing existing experiments in the literature and other scientists can read and rate those reviews.
Tandvård skåne gratis

Scibase

Its products Nevisense and Nevisense View are used for the detection of malignant melanoma.

Invest in SciBase; Rights Issue 2020; Information re conversion of warrants (Swedish only) About Scibase. Business model; Risks and uncertainty; Glossary; Financial data.
Militarligan film

graham brothers
madison police chief
ais sart symbol
empowerment i teori och praktik
medium stockholm susanne ivarsson
hyra dollyvagn uppsala
sjalvinstinkt

Scibase tillförs nära 25 miljoner kronor i övertecknad nyemission. Företrädesemissionen i Scibase blev kraftigt övertecknad och bolaget tillförs 24,9 miljoner kronor före transaktionskostnader.


Debiteringskonto isk
social interaktionism

443 likes · 2 talking about this · 1 was here. SciBase is a medical technology company that has developed a unique point of care device for the accurate detection of melanoma and Scibase AB (556777-3899). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. 2021-04-12 Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. SciBase General Information Description.

Senast bet.

Coming events. 2021-05-12. Interim Report Q1 2021. 2021-05-18. Annual General Meeting 2021. 2021-08-19. Interim Report Q2 2021.